ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements with these filters
Dr. Agarwal's Health Care Limited held its 16th AGM on September 21, 2026. Shareholders approved all agenda items, including financial statements and director re-appointments.
Dr. Agarwal's Health Care Limited has issued the notice for its Sixteenth Annual General Meeting, scheduled for September 21, 2026, alongside its FY 2025-26 Annual Report.
Dr. Agarwals Eye Hospital, a subsidiary, launched the World's First Pinhole Pupilloplasty Centre in Chennai. This facility advances specialized surgical treatments for complex corneal disorders.
Catalyst Trusteeship Limited reported the creation of a pledge over 7,538,303 equity shares of Dr. Agarwal's Health Care Limited, representing 2.38% of its capital.
DB International Trust disclosed a partial release of pledge and disposal of 24,160,000 shares in Dr. Agarwal’s Health Care Ltd. The disclosure complies with Reg 29(2).
Catalyst Trusteeship Limited reported a release of pledge over 3,16,98,303 equity shares of Dr. Agarwal's Health Care Limited. The transaction pertains to a USD 100 million facility.
ICICI Prudential Mutual Fund acquired 1,69,99,999 shares of Dr. Agarwal's Health Care Limited through the open market. This acquisition represents a 5.36% stake in the company.
Dr. Agarwals Health Care will incorporate a new subsidiary, Orbit Health Care Services (Nigeria) Ltd, for Rs.0.70 Crore. This investment supports its Nigerian eye care expansion.
Dr Agarwals Health Care has appointed S.R. Batliboi & Associates LLP as statutory auditor, KPMG as internal auditor, and re-appointed B Y & Associates as cost auditor.
Dr. Agarwal's Health Care Ltd appointed S.R. Batliboi & Associates as Statutory Auditor, KPMG as Internal Auditor, and re-appointed B Y & Associates as Cost Auditor.
Dr. Agarwal’s reported strong Q1FY27 results with revenue of ₹614 Cr and EBITDA of ₹177 Cr. Strategy focuses on aggressive 'Greenfield' expansion and hub-and-spoke scalability across India and Africa.
Dr. Agarwals Health Care Ltd reported revenue from operations of ₹614 Cr (+26.0% YoY) and net profit of ₹55 Cr (+44.4% YoY) for Q1 FY27.
Dr. Agarwal's Health Care Ltd will hold a board meeting on August 4, 2026, to approve financial results and host an earnings conference call.
Dr Agarwals Health Care allotted 43,155 equity shares under its ESOP/ESPS scheme. Post-allotment, the company's paid-up share capital increased to Rs 31,70,26,183.
Dr. Agarwal's Health Care allotted 43,155 equity shares under its 2022 ESOP scheme. Total paid-up capital increased to Rs.31.70 Crore following this allotment.